Terra Tech Corp. (TRTC)

logoTerra Tech Corp is an agricultural company that has entered the US marijuana industry. Since 2012, it has been developing products for controlled plant cultivation, but it is only in early 2014 that it started to explore a medical cannabis business.

Terra Tech’s main business is producing technologies for indoor and outdoor agriculture. These include environmental controllers, plant lighting, horticultural nutrients, and hydroponic trailers. The portable hydroponic trailers are some of its major products. They come in the Big Bud and Little Bud types, and Terra Tech describes them as “the most advanced mobile controlled agricultural facilities”.

The company uses its proprietary technology to design its products, and produces them through partnerships with commercial clients. It also caters to the retail market through its wholly owned subsidiary, GrowOp Technology, Ltd.

At the start of 2014, Terra Tech entered the medical cannabis sector by applying for a Nevada license to operate a marijuana cultivation dispensary and facility. The company is the first among US publicly traded companies to do so. In addition, it formed another subsidiary, Medifarm LLC, to focus on medical marijuana.

Terra Tech was incorporated in 2008 as a VoIP software company named Private Secretary, Inc. In 2012, the company changed its business as a result of its merger with GrowOp Technology, Ltd. This led to the forming of Terra Tech Corp.

Currently, Terra Tech is traded as TRTC in the OTC markets, with a market cap pegged at USD 68.26 M.

Terra Tech’s management team is led by Derek A. Peterson, who is the company’s Founder, Chairman, CEO, and President. Other executives are Co-founders Robert Drust and Eric Kroguis; CFO Michael C. James, and Secretary, Treasurer, and Director Amy Almsteier.


Yahoo! Finance: TRTC News

Latest Financial News for TRTC

Terra Tech Corp. Reports Financial Results for the Third Quarter of 2019

Revenue from continuing operations increased 131% versus the third quarter in 2018 Revenue from continuing and discontinued operations increased 66% versus the third quarter in 2018 IRVINE, CA / ACCESSWIRE ...

Terra Tech Corp. Schedules Third Quarter 2019 Earnings Release for Tuesday, November 12, 2019

IRVINE, CA / ACCESSWIRE / November 7, 2019 / Terra Tech Corp. (OTCQX:TRTC) ("Terra Tech") or (the "Company"), a vertically integrated cannabis-focused agriculture company, today announced ...

OneQor Pharmaceutical Appoints Dr. Joseph Fortunak as Chief Scientific Officer

PHOENIX, AZ / ACCESSWIRE / November 6, 2019 / OneQor Pharmaceutical ("OneQor" or the "Company"), a fully integrated developer and supplier of proprietary, plant-derived products to the pharmaceutical, health, beauty, fitness, and wellness industries which has entered into an Agreement and Plan of Merger to merge with a subsidiary of Terra Tech Corp. (TRTC), today announced the appointment of Dr. Joseph Fortunak as its Chief Scientific Officer. Dr. Fortunak has served as Chair of the Science Committee for OneQor, since February 2019 and has spent 21 years in the pharmaceutical industry, with former roles including head of global chemical development at Abbot Labs. Joseph Fortunak is a Professor of Chemistry and Pharmaceutical Sciences at Howard University in Washington D.C. Dr. Fortunak also holds honorary appointments at several other institutions in the US and overseas.

'Best Use Of The Company's Balance Sheet': Terra Tech, OneQor Pharmaceutical To Merge

Terra Tech Corp (OTC: TRTC), a vertically integrated and cannabis-oriented agricultural company, announced Monday that it has signed an agreement and plan of merger with the private pharmaceutical company OneQor Pharmaceutical. Under the agreement, OneQor will merge with a subsidiary of Terra Tech in an all-stock transaction. The joint company will work on new pharmaceutical growth opportunities for OneQor, and Terra Tech’s portfolio should continue with its operations in the short-term, Terra Tech said in a press release.

Terra Tech Corp. CEO, Derek Peterson and OneQor Pharmaceutical CEO, Matt Morgan, Discuss Planned Merger in an Exclusive New Interview at SmallCapVoice.com

AUSTIN, TX / ACCESSWIRE / November 4, 2019 / SmallCapVoice.com (SCV) and Terra Tech Corp. (TRTC), today announced that Company CEO, Derek Peterson and OneQor Pharmaceutical CEO, Matthew Morgan, are featured in a new audio interview at SmallCapVoice.com. In the interview, Mr. Peterson and Mr. Morgan discuss the recently announced Agreement and Plan of Merger (the "Agreement"), pursuant to which OneQor Pharmaceutical will merge with a wholly owned subsidiary of Terra Tech in an all-stock transaction.